(4S,8R)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-20-[hydroxy-(1-hydroxy-6-oxo-2-pyridinyl)methyl]-25-(1-hydroxy-6-oxopyridine-2-carbonyl)-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-17-carboxamide

C45H56N12O17 — CID 138492940

IUPAC(4S,8R)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-20-[hydroxy-(1-hydroxy-6-oxo-2-pyridinyl)methyl]-25-(1-hydroxy-6-oxopyridine-2-carbonyl)-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-17-carboxamide
SMILESNCCOCCNC(=O)C1CCN(C(O)c2cccc(=O)n2O)CCCCN(C(=O)c2cccc(=O)n2O)CCCNC(=O)c2ccc(c(=O)n2O)C(=O)N[C@@H]2COC[C@@H]2NC(=O)c2ccc(n(O)c2=O)C(=O)N1
InChIInChI=1S/C45H56N12O17/c46-15-22-73-23-17-48-39(62)28-14-21-53(45(68)34-7-4-9-36(59)55(34)70)19-2-1-18-52(44(67)33-6-3-8-35(58)54(33)69)20-5-16-47-40(63)31-12-10-26(42(65)56(31)71)37(60)50-29-24-74-25-30(29)51-38(61)27-11-13-32(41(64)49-28)57(72)43(27)66/h3-4,6-13,28-30,45,68-72H,1-2,5,14-25,46H2,(H,47,63)(H,48,62)(H,49,64)(H,50,60)(H,51,61)/t28?,29-,30+,45?/m1/s1
InChIKeyBYBIGXUMGQNIQH-OEIVXRMMSA-N
MW1037.01 g/mol
LogP-4.16
Rot. Bonds9

About (4S,8R)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-20-[hydroxy-(1-hydroxy-6-oxo-2-pyridinyl)methyl]-25-(1-hydroxy-6-oxopyridine-2-carbonyl)-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-17-carboxamide

(4S,8R)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-20-[hydroxy-(1-hydroxy-6-oxo-2-pyridinyl)methyl]-25-(1-hydroxy-6-oxopyridine-2-carbonyl)-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-17-carboxamide (PubChem CID 138492940) has the molecular formula C45H56N12O17 and a molecular weight of 1037.01 g/mol. Its IUPAC name is (4S,8R)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-20-[hydroxy-(1-hydroxy-6-oxo-2-pyridinyl)methyl]-25-(1-hydroxy-6-oxopyridine-2-carbonyl)-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-17-carboxamide.

Molecular Properties

Compound Name(4S,8R)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-20-[hydroxy-(1-hydroxy-6-oxo-2-pyridinyl)methyl]-25-(1-hydroxy-6-oxopyridine-2-carbonyl)-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-17-carboxamide
PubChem CID138492940
Molecular FormulaC45H56N12O17
Molecular Weight1037.01 g/mol
Exact Mass1036.39
IUPAC Name(4S,8R)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-20-[hydroxy-(1-hydroxy-6-oxo-2-pyridinyl)methyl]-25-(1-hydroxy-6-oxopyridine-2-carbonyl)-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-17-carboxamide
SMILESNCCOCCNC(=O)C1CCN(C(O)c2cccc(=O)n2O)CCCCN(C(=O)c2cccc(=O)n2O)CCCNC(=O)c2ccc(c(=O)n2O)C(=O)N[C@@H]2COC[C@@H]2NC(=O)c2ccc(n(O)c2=O)C(=O)N1
InChIInChI=1S/C45H56N12O17/c46-15-22-73-23-17-48-39(62)28-14-21-53(45(68)34-7-4-9-36(59)55(34)70)19-2-1-18-52(44(67)33-6-3-8-35(58)54(33)69)20-5-16-47-40(63)31-12-10-26(42(65)56(31)71)37(60)50-29-24-74-25-30(29)51-38(61)27-11-13-32(41(64)49-28)57(72)43(27)66/h3-4,6-13,28-30,45,68-72H,1-2,5,14-25,46H2,(H,47,63)(H,48,62)(H,49,64)(H,50,60)(H,51,61)/t28?,29-,30+,45?/m1/s1
InChIKeyBYBIGXUMGQNIQH-OEIVXRMMSA-N
XLogP-4.16
TPSA402.68 Ų
H-Bond Donors11
H-Bond Acceptors23
Rotatable Bonds9
Heavy Atoms74
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001037.01
LogP ≤ 5-4.16
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'N-hydroxyl_pyridine', 'substructure': 'N/A'}

Analyze (4S,8R)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-20-[hydroxy-(1-hydroxy-6-oxo-2-pyridinyl)methyl]-25-(1-hydroxy-6-oxopyridine-2-carbonyl)-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-17-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (4S,8R)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-20-[hydroxy-(1-hydroxy-6-oxo-2-pyridinyl)methyl]-25-(1-hydroxy-6-oxopyridine-2-carbonyl)-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-17-carboxamide?
The IUPAC name of (4S,8R)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-20-[hydroxy-(1-hydroxy-6-oxo-2-pyridinyl)methyl]-25-(1-hydroxy-6-oxopyridine-2-carbonyl)-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-17-carboxamide (CID 138492940) is (4S,8R)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-20-[hydroxy-(1-hydroxy-6-oxo-2-pyridinyl)methyl]-25-(1-hydroxy-6-oxopyridine-2-carbonyl)-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-17-carboxamide.
What is the SMILES notation for (4S,8R)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-20-[hydroxy-(1-hydroxy-6-oxo-2-pyridinyl)methyl]-25-(1-hydroxy-6-oxopyridine-2-carbonyl)-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-17-carboxamide?
The canonical SMILES for (4S,8R)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-20-[hydroxy-(1-hydroxy-6-oxo-2-pyridinyl)methyl]-25-(1-hydroxy-6-oxopyridine-2-carbonyl)-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-17-carboxamide is NCCOCCNC(=O)C1CCN(C(O)c2cccc(=O)n2O)CCCCN(C(=O)c2cccc(=O)n2O)CCCNC(=O)c2ccc(c(=O)n2O)C(=O)N[C@@H]2COC[C@@H]2NC(=O)c2ccc(n(O)c2=O)C(=O)N1.
What is the InChIKey of (4S,8R)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-20-[hydroxy-(1-hydroxy-6-oxo-2-pyridinyl)methyl]-25-(1-hydroxy-6-oxopyridine-2-carbonyl)-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-17-carboxamide?
The InChIKey is BYBIGXUMGQNIQH-OEIVXRMMSA-N. The full InChI is InChI=1S/C45H56N12O17/c46-15-22-73-23-17-48-39(62)28-14-21-53(45(68)34-7-4-9-36(59)55(34)70)19-2-1-18-52(44(67)33-6-3-8-35(58)54(33)69)20-5-16-47-40(63)31-12-10-26(42(65)56(31)71)37(60)50-29-24-74-25-30(29)51-38(61)27-11-13-32(41(64)49-28)57(72)43(27)66/h3-4,6-13,28-30,45,68-72H,1-2,5,14-25,46H2,(H,47,63)(H,48,62)(H,49,64)(H,50,60)(H,51,61)/t28?,29-,30+,45?/m1/s1.
What are the key properties of (4S,8R)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-20-[hydroxy-(1-hydroxy-6-oxo-2-pyridinyl)methyl]-25-(1-hydroxy-6-oxopyridine-2-carbonyl)-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-17-carboxamide?
(4S,8R)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-20-[hydroxy-(1-hydroxy-6-oxo-2-pyridinyl)methyl]-25-(1-hydroxy-6-oxopyridine-2-carbonyl)-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-17-carboxamide has a molecular weight of 1037.01 g/mol, XLogP of -4.16, 9 rotatable bonds, 11 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for (4S,8R)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-20-[hydroxy-(1-hydroxy-6-oxo-2-pyridinyl)methyl]-25-(1-hydroxy-6-oxopyridine-2-carbonyl)-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-17-carboxamide is sourced from PubChem (CID 138492940), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).